This inventor holds 2 USPTO granted patents. Top assignees: Aventis Pharma Deutschland, Gmbh, Nicholas Piramal India Limited. Active years: 2002-2004.
Company Filing History:

Years Active: 2002-2004
Title: Innovations of Ravi Gajanan Bhat
Introduction
Ravi Gajanan Bhat is a notable inventor based in Mumbai, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and processes. With a total of 2 patents to his name, his work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of his latest patents is focused on crystalline glucosamine sulfate metal salts and processes for preparing the same. This invention relates to novel crystalline glucosamine sulfate metal salts that are intended for use in treating acute and chronic forms of rheumatic and arthritic diseases, as well as conditions arising from metabolic disorders of the osteo-articular tissues. The invention emphasizes low metal content, specifically sodium or potassium, and includes a solution-based and solvent-free process for preparation.
Another significant patent is for Vancoresmycin, a compound obtained through the cultivation of the microorganism HIL-006734 (DSM 12216). This invention also covers its pharmaceutically acceptable salts and outlines a process for its production. Vancoresmycin is particularly noted for its use as an antibiotic, along with pharmaceutical compositions that include this compound or its salts.
Career Highlights
Ravi Gajanan Bhat has worked with prominent companies in the pharmaceutical industry, including Nicholas Piramal India Limited and Aventis Pharma Deutschland, GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Throughout his career, he has collaborated with notable professionals such as Triptikumar Mukhopadhyay and E S Sreekumar. These collaborations have likely enriched his research and development efforts.
Conclusion
Ravi Gajanan Bhat's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities involved in drug development and highlight his role as a significant inventor in the industry.